Figure 2

Mammary gland involution markers analysed from mammary gland secretions for the tested doses (0 –control–, 0.012, 0.12, and 12 mg) of inclusion bodies containing matrix metalloproteinase-9 along 0, 1, 2, 3, 6, and 7 d post-infusion. Non-transformed means and SEM (error bars) are represented while P-values were obtained from transformed data, when necessary. Asterisks depict significant differences between treatments and the control group within time. (a) Somatic cell counts (SCC) are expressed in million (106) cells per mL (M cells/ml); P < 0.0001. (b) Bovine serum albumin (BSA); P < 0.0001. For differences between different treatments within each time point, see Table S2 in the Supplementary Material.